International
The Morning Science

What science found today

‹
 

Research

Pharmacist-led SABA overuse case-finding combined with FeNO supported management of high-risk symptomatic patients with asthma: a pilot study

Nature ·

The Brief

  • A pilot study examined pharmacist-led case-finding for short-acting beta-agonist (SABA) overuse in asthma.
  • The approach was combined with fractional exhaled nitric oxide (FeNO) testing to support management of high-risk symptomatic patients.
  • The study was listed in the nature.com subject feed dated 2026-11-20; the available source provides no summary of results.

Why it matters

It describes a possible way to identify asthma patients who overuse reliever inhalers and to support their management, but as a pilot study its effectiveness is not established.

Who’s affected

  • clinicians and pharmacists involved in asthma care
  • people with asthma who rely on reliever inhalers
  • #asthma
  • #pharmacy
  • #saba
  • #feno
  • #respiratory medicine

Timeline

  1. Pilot study appeared in nature.com subject feed

  2. Medical research : nature.com subject feeds

    Pharmacist-led SABA overuse case-finding combined with FeNO supported management of high-risk symptomatic patients with asthma: a pilot study

How do you feel about this?

0 Comments

    Pharmacist-led SABA overuse case-finding combined with FeNO supported management of high-risk symptomatic patients with asthma: a pilot study – The Morning Science